118 related articles for article (PubMed ID: 6148220)
1. Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine.
Cassinelli G; Configliacchi E; Penco S; Rivola G; Arcamone F; Pacciarini A; Ferrari L
Drug Metab Dispos; 1984; 12(4):506-10. PubMed ID: 6148220
[TBL] [Abstract][Full Text] [Related]
2. Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography.
Deesen PE; Leyland-Jones B
Drug Metab Dispos; 1984; 12(1):9-13. PubMed ID: 6141919
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of aclacinomycin A and its metabolites from human urine.
Egorin MJ; Andrews PA; Nakazawa H; Bachur NR
Drug Metab Dispos; 1983; 11(2):167-71. PubMed ID: 6133724
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.
Camaggi CM; Comparsi R; Strocchi E; Testoni F; Angelelli B; Pannuti F
Cancer Chemother Pharmacol; 1988; 21(3):221-8. PubMed ID: 3162849
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
6. Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection.
Dine T; Brunet C; Luyckx M; Cazin M; Gosselin P; Cazin JL
Biomed Chromatogr; 1990 Jan; 4(1):20-3. PubMed ID: 2310837
[TBL] [Abstract][Full Text] [Related]
7. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of N, N-di(n-butyl)doxorubicin-14-valerate and its 8 urinary metabolites by HPLC.
Han GZ; Seshadri R
Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):102-7. PubMed ID: 7597906
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of urinary metabolites of porfiromycin in dogs and humans.
Lang W; Mao J; Doyle TW; Almassian B
Drug Metab Dispos; 2000 Aug; 28(8):899-904. PubMed ID: 10901698
[TBL] [Abstract][Full Text] [Related]
10. HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids.
Camaggi CM; Comparsi R; Strocchi E; Testoni F; Pannuti F
Cancer Chemother Pharmacol; 1988; 21(3):216-20. PubMed ID: 3162848
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
12. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
[TBL] [Abstract][Full Text] [Related]
13. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
Taatjes DJ; Fenick DJ; Koch TH
J Med Chem; 1998 Apr; 41(8):1306-14. PubMed ID: 9548820
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects.
Neri B; Cini-Neri G; Bandinelli M; Pacini P; Bartalucci S; Ciapini A
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):217-21. PubMed ID: 2737789
[TBL] [Abstract][Full Text] [Related]
15. Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients.
Camaggi CM; Strocchi E; Comparsi R; Testoni F; Angelelli B; Pannuti F
Cancer Chemother Pharmacol; 1986; 18(1):47-50. PubMed ID: 3463434
[TBL] [Abstract][Full Text] [Related]
16. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
17. Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx).
Stillwell WG; Turesky RJ; Gross GA; Skipper PL; Tannenbaum SR
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):399-405. PubMed ID: 7920207
[TBL] [Abstract][Full Text] [Related]
18. Daunorubicin metabolites in human urine.
Takanashi S; Bachur NR
J Pharmacol Exp Ther; 1975 Oct; 195(1):41-9. PubMed ID: 1181403
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of proxyphylline in man. Isolation and identification of metabolites in urine.
Selvig K; Bjerve KS
Drug Metab Dispos; 1980; 8(6):456-62. PubMed ID: 6109616
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
MacGregor TR; Nastasi L; Farina PR; Keirns JJ
Drug Metab Dispos; 1983; 11(6):568-73. PubMed ID: 6140141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
